| Infarct-like (n = 23) | Heart failure (n = 18) | p values |
---|---|---|---|
Demographics | |||
 Age (years) | 39.6 ± 13.9 | 38.3 ± 13.2 | 0.78 |
 Sex, male (n, %) | 16 (69.6) | 8 (44.4) | 0.13 |
 HIV + (n, %) | 4 (17.4) | 6 (33.3) | 0.29 |
Laboratory investigation | |||
 Hs-cTnT (ng/L) | 724 (270–1361) | 104 (35–499) | 0.002 |
 Hs-cTnT > 100 ng/L (n, %) | 21 (91.3) | 8 (44.4) | 0.002 |
TTE parameter | |||
 LVEDD (mm) | 48.1 ± 6.9 | 52.1 ± 6.1 | 0.06 |
Endomyocardial biopsy | |||
 Dallas criteria (n, %) | 8 (34.8) | 6 (33.3) | 1.00 |
 IHC criteria (n, %) | 15 (65.2) | 12 (66.7) |  |
Viral genomes detected (n, %) | 17 (73.9) | 11 (61.1) | 0.50 |
 Parvovirus B19 | 12 | 7 | 0.53 |
 Epstein-Barr Virus | 2 | 2 |  |
 Human Herpes Virus 6 | 1 | 1 |  |
 Human Bocavirus | 1 | 0 |  |
 Enterovirus | 0 | 0 |  |
 Adenovirus | 0 | 0 |  |
 PVB19/EBV | 1 | 0 |  |
 PVB19/EBV/HHV6 | 0 | 1 |  |